REVIEW ON OCULAR DRUG DELIVERY SYSTEM AND ITS DEVICES
Journal Title: International Journal of Drug Regulatory Affairs - Year 2014, Vol 2, Issue 3
Abstract
Ocular drug delivery system for the treatment of eye diseases has become popular and feasible in the past few years. Improving ocular contact time, enhancing corneal permeability and site specificity are the key points for the optimization of ocular drug delivery. Use of polymers such as ethylene vinyl acetate copolymer can increase the solution viscosity and decrease the drainage of solution, thereby increasing the contact time and its bioavailabilty. There are various types of ocular drug release system such as ocusert, contact lenses, diffusional inserts which falls under the category of non-erodible ocular controlled release system, lacrisert, soluble ocular delivery implant(SODI), minidisc which falls under the category of erodible ocular controlled release system; nanoparticles; liposomes. Episcleral, intrascleral and suprachoroidal routes have the advantage of bypassing the main barriers to topical drug penetration. This type of delivery system provides a controlled release of drug for a long period of time. This type of delivery system has good patient compliance. Acuvue, lacrisert; biomedics are the most common marketed products of ocular drug delivery system. This manuscript will review the recent research advances on ocular drug delivery system and their types.
Authors and Affiliations
Nikhil Gulati, Vanya Dwivedi
Keywords
Related Articles
- EP ID EP349845
- DOI 10.22270/ijdra.v2i3.145
- Views 96
- Downloads 0
Current Regulatory requirements for Registration of Nutraceuticals in India and USA
There is growing recognition of the potential role for nutraceuticals and dietary supplements in helping to reduce health risks and improve health quality. Pharmaceutical and nutritional companies are aware of the moneta...
A REVIEW ON DRUG APPROVAL PROCESS FOR US, EUROPE AND INDIA
Developing a new drug requires great amount of research work in chemistry, manufacturing, controls, preclinical science and clinical trials. Drug reviewers in regulatory agencies around the world bear the responsibility...
DMF FILING IN US, EUROPE AND CANADA
A Drug Master File or DMF is a reference source that provides drug evaluator’s confidential information not available to drug product manufacturer about the specific process and components used in the manufacturing, proc...
Regulatory requirements for the approval of Anti-Cancer drug (Mercaptopurine) in Myanmar as per ACTD
South East Asian pharmaceutical market is growing rapidly. In Asian country, the regulatory environment is similar among all countries. But still requirements and process of registration is varying among countries of Asi...
METHOD DEVELOPMENT AND VALIDATION OF STABILITY INDICATING UPLC ASSAY METHOD FOR NIFEDIPINE
A simple and rapid stability indicating, ultra performance liquid chromatographic (UPLC) method was developed and validated for the determination of Nifedipine. The quantitative determination of Nifedipine drug was perfo...